The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods.
Lucia E, Martino B, Mammi C, Vigna E, Mazzone C, Gentile M, Qualtieri G, Bisconte MG, Naccarato M, Gentile C, Laganà C, Romeo F, Neri A, Nobile F, Morabito F.
Lucia E, et al. Among authors: gentile m, gentile c.
Leuk Lymphoma. 2008 Oct;49(10):1907-15. doi: 10.1080/10428190802290652.
Leuk Lymphoma. 2008.
PMID: 18720212